The department’s newsroom website stated that the vaccine uses virus-like particles (VLPs) to eliminate the tangling of the tau protein, which when accumulated in the brain can interrupt neurons in the brain from communicating. Alzheimer’s, which is expected to strike triple the number of people by 2050, cripples the brain as human beings age, as beta-amyloid proteins in the brain get stuck together and tau proteins start to tangle, both of which inhibit neural connections.
Too early to get excited. This treatment hasn’t even started testing and approval by the FDA. That’s years for most drugs. But it’s encouraging.